Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis-Reference-Cited by-同舟云学术

Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis

Published:2004-01-01 Issue:5 Volume:38 Page:427-433
ISSN:0036-5599
Container-title:Scandinavian Journal of Urology and Nephrology
language:en
Short-container-title:Scandinavian Journal of Urology and Nephrology

Author:

Renke Marcin¹,Tylicki Leszek¹,Rutkowski Przemyslaw¹,Rutkowski Boleslaw¹

Affiliation:

1. Department of Nephrology, Transplantology and Internal Medicine Medical University of Gdansk Gdansk Poland

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365590410015687

Reference33 articles.

1. Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists

2. State of the Art Lecture: Erythropoietin receptor: application in drug development

3. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of traditional Chinese medicine versus angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and their combinations in the treatment of IgA nephropathy: a systematic review and network meta-analysis;Frontiers in Pharmacology;2024-03-21

2. Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Combination with Angiotensin-Receptor Blockers in Nondiabetic Chronic Kidney Disease: A Systematic Review and Meta-Analysis;Current Medicinal Chemistry;2021-12-08

3. Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease;Medicine;2021-09-03

4. Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs;PeerJ;2021-07-06

5. Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2021-05-06